Optimized pseudotyping conditions for the SARS-COV2 Spike glycoprotein
M. C. Johnson, T. D. Lyddon, R. Suarez, B. Salcedo, M. LePique, M. Graham, C. Ricana, C. Robinson, D. G. Ritter
This paper optimizes conditions for generating SARS-CoV-2 Spike pseudotyped viral particles, achieving high titers and demonstrating their utility in detecting neutralizing antibodies in COVID-19 patient plasma.
bioRxiv · May 28, 2020Microbiology